Connect Biopharma Holdings Limited Proceeds From Other Longterm Assets Classified As Investing Activities
Connect Biopharma Holdings Limited (CNTB) reported Proceeds From Other Longterm Assets Classified As Investing Activities of $2.94 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-16.
Discontinued › Cash Flow › Investing Activities
ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities · last filed 2024-04-16
| Period end | Proceeds From Other Longterm Assets Classified As Investing Activities 12 month |
|---|---|
| 2023-12-31 | $2.94M 20-F · filed 2024-04-16 |
| 2022-12-31 | $0.00 20-F · filed 2024-04-16 |
| 2021-12-31 | $0.00 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |